SCHEMBL442820

SCHEMBL442820

Oc1cocc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153633 0.75
SCHEMBL5151198 0.75
SCHEMBL351954 0.69
SCHEMBL4651248 0.56
SCHEMBL5378423 0.55
SCHEMBL10762944 0.55
SCHEMBL7260799 0.55
Catechol SCHEMBL20597824 0.55
SCHEMBL2084015 0.55
SCHEMBL8414008 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119081799-A Photoresist cleaning solution and preparation method and application thereof 上海盛剑微电子有限公司 2024-12-06 CN claimed
CN-118344770-A Jet printing ink and application thereof 惠州市鹏程电子科技有限公司 2024-07-16 CN claimed
EP-3010959-B1 METHOD FOR PREPARING DIOXYHETEROCYCLE-BASED ELECTROCHROMIC POLYMERS UNIV FLORIDA (US) 2021-04-21 EP claimed
US-20210111346-A1 CONJUGATED POLYMERS WITH MULTISTAGE SIDE-CHAIN CLEAVAGE NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2021-04-15 US claimed
US-10751303-B2 Method for shortening anti-infective therapy duration in subjects with infection INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (US) 2020-08-25 US claimed
WO-2019005247-A9 CONJUGATED POLYMERS WITH MULTISTAGE SIDE-CHAIN CLEAVAGE GEORGIA TECH RESEARCH CORPORATION (US) 2019-03-07 WO claimed
WO-2019005247-A1 CONJUGATED POLYMERS WITH MULTISTAGE SIDE-CHAIN CLEAVAGE GEORGIA TECH RESEARCH CORPORATION (US) 2019-01-03 WO claimed
US-20180015055-A1 METHOD FOR SHORTENING ANTI-INFECTIVE THERAPY DURATION IN SUBJECTS WITH INFECTION INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (US) 2018-01-18 US claimed
EP-3250194-A1 METHOD FOR SHORTENING ANTI-INFECTIVE THERAPY DURATION IN SUBJECTS WITH INFECTION Institute for Clinical Pharmacodynamics, Inc. (US) 2017-12-06 EP claimed
US-9795572-B2 Method for shortening anti-infective therapy duration in subjects with infection INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (US) 2017-10-24 US claimed
EP-1838673-A1 PROCESS FOR MAKING SUBSTITUTED PIPERIDINES Merck & Co., Inc. (US) 2007-10-03 EP claimed
WO-2006069287-A1 PROCESS FOR MAKING SUBSTITUTED PIPERIDINES MERCK & CO., INC. (US) 2006-06-29 WO claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
CN-1202118-C Adenosine derivatives GLAXO GROUP LTD (GB) 2005-05-18 CN claimed
CN-1314910-A Adenosine derivatives GLAXO GROUP LTD (GB) 2001-09-26 CN claimed
EP-0532120-B1 Process for the preparation of 4-hydroxy-3(2H)furanones TASTEMAKER BV (NL) 1998-01-07 EP claimed
US-5527899-A STABILIZATION THE SINGLE-STRAND OLIGONUCLEOTIDE TO EXONUCLEASE DEGRADATION GILEAD SCIENCES, INC. (US) 1996-06-18 US claimed
US-5412121-A Process for the preparation of 4-hydroxy-3[2H]furanones TASTEMAKER (US) 1995-05-02 US claimed
US-5399676-A DNA sequence identification GILEAD SCIENCES (US) 1995-03-21 US claimed
EP-0532120-A1 Process for the preparation of 4-hydroxy-3(2H)furanones Tastemaker B.V. (NL) 1993-03-17 EP claimed